Estimation of the impact of genital warts on health-related quality of life

Sexually Transmitted Infections

Volumn 84, Issue 3, 2008, Pages 161-166

  Woodhall, S ^a,b   Ramsey, T ^b   Cai, C ^b   Crouch, S ^a   Jit, M ^c   Birks, Y ^a   Edmunds, W J ^c   Newton, R ^a   Lacey, C J N ^a,b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Department of GU Medicine   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; UNITED KINGDOM; VISUAL ANALOG SCALE; ADOLESCENT; ANXIETY; CASE CONTROL STUDY; DAILY LIFE ACTIVITY; HEALTH STATUS; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; PAIN; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; ANXIETY; CASE-CONTROL STUDIES; CONDYLOMATA ACUMINATA; FEMALE; HEALTH STATUS; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 45549093614     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.029512     Document Type: Article

References (30)

1. Department of Health. HPV vaccine recommended for NHS immunisation programme. 26 October 2007. http://www.gnn.gov.uk/environment/fullDetail.asp? ReleaseID=325799&NewsAreaID=2 (accessed March 2008).
2. Bosch X, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monographs 2003;31:3-13.
3. Brown DR, Schroeder DM, Bryan JT, et al. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999;37:3316-22.
4. Health Protection Agency. All new STI episodes seen at GUM clinics in the UK: 1997-2006. http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/ Stats/STIs/Annual/2006/UK_Country_Sex_1997-2006.pdf (accessed 20 Mar 2008).
5. Health Protection Agency. 2006 STI data, http://www.hpa.org.uk/ infections/topics_az/hiv_and_sti/Stats/STIs/Annual/2006/general.htm (accessed 20 Mar 2008).
6. Lacey CJN, Lowndes CM, Shah KV. Burden and management of non-cancerous HPV-related conditions: HPV 6-11 disease. Vaccine 2006;24(Suppl 3):S3-35; S41.
7. Newall AT, Beutels P, Wood JG, et al. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 2007;7:289-96.
8. Conaglen HM, Hughes R, Conaglen JV, et al. A prospective study of the psychological impact on patients of first diagnosis of human papillomavirus. Int J STD AIDS 2001;12:651-8.
9. Ireland J. The role of illness perceptions: psychological distress and treatment-seeking delay in patients with genital warts. Int J STD AIDS 2005;16:667-70.
10. Maw RD. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-8.
11. Persson G, Dahlof LG, Krantz I. Physical and psychological effects of anogenital warts on female patients. Sex Transm Dis 1992;20:10-13.
12. Schofield MJ, Minichiello V, Mishra GD, et al. Sexually transmitted infections and use of sexual health services among young Australian women: Women's Health Australia Study. Int J STD AIDS 2000;11:313-23.
13. Myers ER, Green S, Lipkus I. Patient preferences for health states related to HPV infection: visual analog scales vs time trade-off elicitation. Proceedings of the 21st International Papillomavirus Conference; Mexico, 2004.
14. Brisson M, Van de Velde N, De Wals P, et al. The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine 2007;25:5399-408.
15. Lacey CJN. Genital warts: epidemiological, laboratory, and therapeutic studies. London: University of London, 2006.
16. Kind P, Dolan P, Gudex C, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41.
17. The UK Collaborative Group for HIV and STI Surveillance. A complex picture. HIV and other sexually transmitted infections in the United Kingdom: 2006. London: Health Protection Agency, Centre for Infections, 2006.
18. Badia X, Colombo JA, Lara N, et al. Combination of qualitative and quantitative methods for developing a new health related quality of life measure for patients with anogenital warts. Health Dual Life Outcomes 2005;3:24.
19. Wood SN. Generalized additive models: an introduction with R. Boca Raton, FL, USA: Chapman and Hall/CRC, 2006.
20. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2007.
21. Chen SC, Bayoumi AM, Soon SL, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 2004;9:160-8.
22. Stratton KR, Lawrence RS, Durch JS, editors. Vaccines for the 21st century: a tool for decisionmaking. Washington, DC, USA: The National Academies Press, 2000.
23. Osborn DP, King MB, Weir M. Psychiatric health in a sexually transmitted infections clinic: effect on reattendance. J Psychosom Res 2002;52:267-72.
24. Patel R, Boselli F, Cairo I, et al. Patients' perspectives on the burden of recurrent genital herpes. Int J STD AIDS 2001;12:640-5.
25. Taboulet F, Halioua B, Malkin JE. Quality of life and use of health care among people with genital herpes in France. Acta Dermato-Venereologica 1999;79:380-4.
26. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl 1996;100:27-32.
27. Ikkos G, Fitzpatrick R, Frost D, et al. Psychological disturbance and illness behaviour in a clinic for sexually transmitted diseases. Br J Med Psychol 1987;60:121-6.
28. Insinga BP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003;36:1397-403.
29. Langley PC, White DJ, Drake SM. The costs of treating external genital warts in England and Wales: a treatment pattern analysis. Int J STD AIDS 2004;15:501-8.
30. Brown RE, Breugelmans JG, Theodoratou D, et al. Costs and detection of treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 2006;22:663-70.